Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies
Stopped early · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C)
In brief
Phase 1/2 study to determine safety, tolerability, pharmacokinetics, and anti-leukemic activity of Vodobatinib (K0706) in treatment-refractory/intolerant CML
Key facts
- Study ID
- NCT02629692
- Run by
- Sun Pharma Advanced Research Company Limited
- People needed
- 124
- Starts
- 2016-06-27
- Expected to finish
- 2025-01-03
- Last updated by the study team
- 2026-05-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The Oncology Institute of Hope and Innovation, Innovative Clinical Research Institute — Downey, California, United States
- UCLA Hematologic Malignancy Program — Los Angeles, California, United States
- Mayo Clinic — Jacksonville, Florida, United States
- Board of Regents of the University System of Georgia — Augusta, Georgia, United States
- Memorial Sloan Kettering Cancer Center - MAIN — New York, New York, United States
- Baylor University Medical Center — Dallas, Texas, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Huntsman Cancer Institute University of Utah — Salt Lake City, Utah, United States
- Cliniques Universitaires Saint-Luc — Brussels, Belgium
- Institut Paoli Calmettes — Marseille, Bouches-du-Rhône, France
- Centre Léon Bérard — Lyon, Rhone, France
- Centre Hospitalier Lyon Sud — Pierre-Bénite, Rhone, France
- Debreceni Egyetem — Debrecen, Hungary
- Prince Aly Khan Hospital — Mumbai, Maharashtra, India
- Tata Memorial Hospital — Mumbai, Maharashtra, India
- Sahyadri Specialty Hospital — Pune, Maharashtra, India
- Meenakshi Mission Hospital & Research Centre — Madurai, Tamil Nadu, India
- Tata Medical Centre — Kolkata, West Bengal, India
- Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori — Meldola, Forli - Cesena, Italy
- Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo) — Monza, Milano, Italy
- Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico — Milan, Italy
- Ospedale Sant'Eugenio — Roma, Italy
- Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza — Roma, Italy
- Spitalul Clinic Colentina — Bucharest, Romania
- Institutul Oncologic "Prof. Dr. Ion Chiricuta" Cluj-Napoca — Cluj-Napoca, Romania
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.